Nashik doctors performed India’s first bariatric interventional procedure for weight loss on a 45-year-old man who weighed 138 kilos. This non-invasive procedure for weight loss is usually practiced for stopping bleeding in stomach or treating stomach ulcers.
“It is a routine interventional radiology procedure to treat bleeding in stomach and ulcer. It was observed that such patients later underwent weight loss. When studied in abroad, doctors found that there was a drastic decrease in satiate hormone which leads to weight loss,” said Dr Sujit Kadam, the physician, who headed the team of doctors who conducted India’s first interventional bariatric procedure.
Kadam said, “as per the study done in abroad, the procedure promises a 20-30 per cent weight loss in six months. “It is a safer procedure as compared to sleeve gastrectomy or gastric bypass. With the help of micro catheter, we enter the patient body from the biggest artery in the leg and then enter gastric artery (one of the four arteries that supplies blood to stomach). Then PVA particles (gel-based) is released in the terminal branches of the left gastric artery. This area produces satiate hormones.”
The procedure was conducted by interventional radiologist Dr. Amol Bhalekar along with Dr. Sujit Kadam and his team.
However, the bariatric surgeons have questioned the procedure for weight loss. “In abroad, this procedure was performed but it didn’t have a desirable result. We would have to wait and watch on how this patient recovers in next three to six months before we talk about the success of the procedure,” said Dr Manish Motwani, bariatric surgeon, Astha Healthcare, Mulund.
“It was an experimental procedure that was tried in West in couple of institutes on small series of patients, but it has been inconclusive. We don’t know the side effects of the procedure, nor do we know the long-term results of the weight loss,” said Dr Jaydeep Palep, bariatric surgeon at Kokilaben Dhirubhai Ambani Hospital.
Dr Sanjay Borude, bariatric surgeon at Breach Candy Hospital said since the procedure is under research and doesn’t have a US FDA approval, it is an ethical issue. “Since has not been approved by US FDA, it can’t be used on human as a therapeutic process,” he added.